The Experts below are selected from a list of 65568 Experts worldwide ranked by ideXlab platform

Ziyad M Hijazi - One of the best experts on this subject based on the ideXlab platform.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Journal of the American College of Cardiology, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, Additional Supporting Information may be found in the online version of this article. The

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Catheterization and Cardiovascular Interventions, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    PREAMBLE With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) have Partnered to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns transcatheter pulmonic valve Replacement (tPVR). tPVR procedures are in their infancy with few reports available on which to base an expert consensus statement. Therefore, many of these recommendations are based on expert consensus and the few reports available. As the procedures evolve, technology advances, experience grows, and more data accumulate, there will certainly be a need to update this consensus statement. The writing committee and Participating societies believe that the recommendations in this report serve as appropriate requisites. In some ways, these recommendations apply to institutions more than to individuals. There is a strong consensus that these new valve therapies are best performed using a Heart Team approach; thus, these credentialing criteria should be applied at the institutional level. Partnering societies used the ACC's policy on relationships with industry (RWI) and other entities to author this document (http://www.acc.org/guidelines/about-guidelines-and-clinical-documents). To avoid actual, potential, or perceived conflicts of interest due to industry relationships or personal interests, all members of the writing committee, as well as peer reviewers of the document, were asked to disclose all current healthcare-related relationships including those existing 12 months before the initiation of the writing effort. A committee of interventional cardiologists and surgeons was formed to include a majority of members with no relevant RWI and to be led by an interventional cardiology cochair and a surgical cochair with no relevant RWI. Authors with relevant RWI were not permitted to draft or vote on text or recommendations pertaining to their RWI. RWI were reviewed on all conference calls and updated as changes occurred. Author and peer reviewer RWI pertinent to this document are disclosed in the Appendices. In addition, to ensure complete transparency, authors' comprehensive disclosure information (including RWI not pertinent to this document) is available in Appendix AII. The work of the writing committee was supported exclusively by the Partnering societies without commercial support. SCAI, AATS, ACC, and STS believe that adherence to these recommendations will maximize the chances that these therapies will become a successful Part of the armamentarium for treating valvular heart disease in the United States. In addition, these recommendations will hopefully facilitate optimum quality during the delivery of this therapy, which will be important to the development and successful implementation of future, less invasive approaches to structural heart disease.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Catheterization and Cardiovascular Interventions, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) have Partnered to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns transcatheter pulmonic valve Replacement (tPVR). tPVR procedures are in their infancy with few reports available on which to base an expert consensus statement. Therefore, many of these recommendations are based on expert consensus and the few reports available. As the procedures evolve, technology advances, experience grows, and more data accumulate, there will certainly be a need to update this consensus statement. The writing committee and Participating societies believe that the recommendations in this report serve as appropriate requisites. In some ways, these recommendations apply to institutions more than to individuals. There is a strong consensus that these new valve therapies are best performed using a Heart Team approach; thus, these credentialing criteria should be applied at the institutional level. Partnering societies used the ACC's policy on relationships with industry (RWI) and other entities to author this document (http://www.acc.org/guidelines/about-guidelines-and-clinical-documents). To avoid actual, potential, or perceived conflicts of interest due to industry relationships or personal interests, all members of the writing committee, as well as peer reviewers of the document, were asked to disclose all current healthcare-related relationships including those existing 12 months before the initiation of the writing effort. A committee of interventional cardiologists and surgeons was formed to include a majority of members with no relevant RWI and to be led by an interventional cardiology cochair and a surgical cochair with no relevant RWI. Authors with relevant RWI were not permitted to draft or vote on text or recommendations pertaining to their RWI. RWI were reviewed on all conference calls and updated as changes occurred. Author and peer reviewer RWI pertinent to this document are disclosed in the Appendices. In addition, to ensure complete transparency, authors' comprehensive disclosure information (including RWI not pertinent to this document) is available in Appendix AII. The work of the writing committee was supported exclusively by the Partnering societies without commercial support. SCAI, AATS, ACC, and STS believe that adherence to these recommendations will maximize the chances that these therapies will become a successful Part of the armamentarium for treating valvular heart disease in the United States. In addition, these recommendations will hopefully facilitate optimum quality during the delivery of this therapy, which will be important to the development and successful implementation of future, less invasive approaches to structural heart disease.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    The Journal of Thoracic and Cardiovascular Surgery, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    Cardiac Catheterization Laboratory, North Shore Shore University Health System, 9669 North Ke 60076; Cardiothoracic Surgery, University of Colo Colorado 88045-2527; Cardiac Catheterization Hospital, Evanston, Illinois 60201; Cardiology Di pital, Walgreen Building 3rd Floor, Evanston, Illinoi Washington School of Medicine, Seattle, Washin Regional Heart Center, 1959 NE Pacific, Box 356171 98195; Rush Center for Congenital & Structural H Illinois 60612; Pediatric Cardiology, Rush Unive Chicago, Illinois 60612; Peter Munk Cardiac Cen Hospital, Toronto, Ontario M5G2C4; Saint Vincent Medical Center/Fallon Clinic, Worcester, Massach medical Associates, Northborough, Massachusetts; Center, Los Angeles, California 90048; DePartmen Health & Science University, 2761 SW Patton Ct., Po Lenox Hill Heart and Vascular Institute of New York 10021; Division of Cardiothoracic Surgery, delphia, Pennsylvania 19104; Cardiovascular C Hospital Baylor Plano, Plano, Texas 75093; The Da Broccoli Center for Aortic Diseases, The John

  • multisociety aats accf scai and sts expert consensus statement operator and institutional requirements for transcatheter valve repair and Replacement Part 1 transcatheter aortic valve Replacement
    Catheterization and Cardiovascular Interventions, 2012
    Co-Authors: Carl L Tommaso, Morton R Bolman, Ted Feldman, Joseph E Bavaria, Michael A Acker, Gabriel S Aldea, Duke E Cameron, Larry S Dean, Dave Fullerton, Ziyad M Hijazi
    Abstract:

    PREAMBLE The granting of staff privileges to physicians is an important mechanism to ensure quality care. The Joint Commission on Accreditation of Healthcare Organizations requires that medical staff privileges be based on professional criteria specified in medical staff bylaws. Physicians are charged with defining the criteria that constitute professional competence and with evaluating their peers accordingly. With the evolution of transcatheter aortic valve Replacement (TAVR), an important opportunity arises for both cardiologists and surgeons to come together to identify the criteria for performing these procedures. The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology Foundation (ACCF), and the Society of Thoracic Surgeons (STS) have, therefore, joined together to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns TAVR. As TAVR is in its infancy, there are few data on which to base this consensus statement. Therefore, many of these recommendations are based on expert consensus. As the procedures

Carl L Tommaso - One of the best experts on this subject based on the ideXlab platform.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Journal of the American College of Cardiology, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, Additional Supporting Information may be found in the online version of this article. The

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Catheterization and Cardiovascular Interventions, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    PREAMBLE With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) have Partnered to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns transcatheter pulmonic valve Replacement (tPVR). tPVR procedures are in their infancy with few reports available on which to base an expert consensus statement. Therefore, many of these recommendations are based on expert consensus and the few reports available. As the procedures evolve, technology advances, experience grows, and more data accumulate, there will certainly be a need to update this consensus statement. The writing committee and Participating societies believe that the recommendations in this report serve as appropriate requisites. In some ways, these recommendations apply to institutions more than to individuals. There is a strong consensus that these new valve therapies are best performed using a Heart Team approach; thus, these credentialing criteria should be applied at the institutional level. Partnering societies used the ACC's policy on relationships with industry (RWI) and other entities to author this document (http://www.acc.org/guidelines/about-guidelines-and-clinical-documents). To avoid actual, potential, or perceived conflicts of interest due to industry relationships or personal interests, all members of the writing committee, as well as peer reviewers of the document, were asked to disclose all current healthcare-related relationships including those existing 12 months before the initiation of the writing effort. A committee of interventional cardiologists and surgeons was formed to include a majority of members with no relevant RWI and to be led by an interventional cardiology cochair and a surgical cochair with no relevant RWI. Authors with relevant RWI were not permitted to draft or vote on text or recommendations pertaining to their RWI. RWI were reviewed on all conference calls and updated as changes occurred. Author and peer reviewer RWI pertinent to this document are disclosed in the Appendices. In addition, to ensure complete transparency, authors' comprehensive disclosure information (including RWI not pertinent to this document) is available in Appendix AII. The work of the writing committee was supported exclusively by the Partnering societies without commercial support. SCAI, AATS, ACC, and STS believe that adherence to these recommendations will maximize the chances that these therapies will become a successful Part of the armamentarium for treating valvular heart disease in the United States. In addition, these recommendations will hopefully facilitate optimum quality during the delivery of this therapy, which will be important to the development and successful implementation of future, less invasive approaches to structural heart disease.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Catheterization and Cardiovascular Interventions, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) have Partnered to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns transcatheter pulmonic valve Replacement (tPVR). tPVR procedures are in their infancy with few reports available on which to base an expert consensus statement. Therefore, many of these recommendations are based on expert consensus and the few reports available. As the procedures evolve, technology advances, experience grows, and more data accumulate, there will certainly be a need to update this consensus statement. The writing committee and Participating societies believe that the recommendations in this report serve as appropriate requisites. In some ways, these recommendations apply to institutions more than to individuals. There is a strong consensus that these new valve therapies are best performed using a Heart Team approach; thus, these credentialing criteria should be applied at the institutional level. Partnering societies used the ACC's policy on relationships with industry (RWI) and other entities to author this document (http://www.acc.org/guidelines/about-guidelines-and-clinical-documents). To avoid actual, potential, or perceived conflicts of interest due to industry relationships or personal interests, all members of the writing committee, as well as peer reviewers of the document, were asked to disclose all current healthcare-related relationships including those existing 12 months before the initiation of the writing effort. A committee of interventional cardiologists and surgeons was formed to include a majority of members with no relevant RWI and to be led by an interventional cardiology cochair and a surgical cochair with no relevant RWI. Authors with relevant RWI were not permitted to draft or vote on text or recommendations pertaining to their RWI. RWI were reviewed on all conference calls and updated as changes occurred. Author and peer reviewer RWI pertinent to this document are disclosed in the Appendices. In addition, to ensure complete transparency, authors' comprehensive disclosure information (including RWI not pertinent to this document) is available in Appendix AII. The work of the writing committee was supported exclusively by the Partnering societies without commercial support. SCAI, AATS, ACC, and STS believe that adherence to these recommendations will maximize the chances that these therapies will become a successful Part of the armamentarium for treating valvular heart disease in the United States. In addition, these recommendations will hopefully facilitate optimum quality during the delivery of this therapy, which will be important to the development and successful implementation of future, less invasive approaches to structural heart disease.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    The Journal of Thoracic and Cardiovascular Surgery, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    Cardiac Catheterization Laboratory, North Shore Shore University Health System, 9669 North Ke 60076; Cardiothoracic Surgery, University of Colo Colorado 88045-2527; Cardiac Catheterization Hospital, Evanston, Illinois 60201; Cardiology Di pital, Walgreen Building 3rd Floor, Evanston, Illinoi Washington School of Medicine, Seattle, Washin Regional Heart Center, 1959 NE Pacific, Box 356171 98195; Rush Center for Congenital & Structural H Illinois 60612; Pediatric Cardiology, Rush Unive Chicago, Illinois 60612; Peter Munk Cardiac Cen Hospital, Toronto, Ontario M5G2C4; Saint Vincent Medical Center/Fallon Clinic, Worcester, Massach medical Associates, Northborough, Massachusetts; Center, Los Angeles, California 90048; DePartmen Health & Science University, 2761 SW Patton Ct., Po Lenox Hill Heart and Vascular Institute of New York 10021; Division of Cardiothoracic Surgery, delphia, Pennsylvania 19104; Cardiovascular C Hospital Baylor Plano, Plano, Texas 75093; The Da Broccoli Center for Aortic Diseases, The John

  • multisociety aats accf scai and sts expert consensus statement operator and institutional requirements for transcatheter valve repair and Replacement Part 1 transcatheter aortic valve Replacement
    Catheterization and Cardiovascular Interventions, 2012
    Co-Authors: Carl L Tommaso, Morton R Bolman, Ted Feldman, Joseph E Bavaria, Michael A Acker, Gabriel S Aldea, Duke E Cameron, Larry S Dean, Dave Fullerton, Ziyad M Hijazi
    Abstract:

    PREAMBLE The granting of staff privileges to physicians is an important mechanism to ensure quality care. The Joint Commission on Accreditation of Healthcare Organizations requires that medical staff privileges be based on professional criteria specified in medical staff bylaws. Physicians are charged with defining the criteria that constitute professional competence and with evaluating their peers accordingly. With the evolution of transcatheter aortic valve Replacement (TAVR), an important opportunity arises for both cardiologists and surgeons to come together to identify the criteria for performing these procedures. The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology Foundation (ACCF), and the Society of Thoracic Surgeons (STS) have, therefore, joined together to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns TAVR. As TAVR is in its infancy, there are few data on which to base this consensus statement. Therefore, many of these recommendations are based on expert consensus. As the procedures

Carlos E Ruiz - One of the best experts on this subject based on the ideXlab platform.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Journal of the American College of Cardiology, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, Additional Supporting Information may be found in the online version of this article. The

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Catheterization and Cardiovascular Interventions, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    PREAMBLE With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) have Partnered to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns transcatheter pulmonic valve Replacement (tPVR). tPVR procedures are in their infancy with few reports available on which to base an expert consensus statement. Therefore, many of these recommendations are based on expert consensus and the few reports available. As the procedures evolve, technology advances, experience grows, and more data accumulate, there will certainly be a need to update this consensus statement. The writing committee and Participating societies believe that the recommendations in this report serve as appropriate requisites. In some ways, these recommendations apply to institutions more than to individuals. There is a strong consensus that these new valve therapies are best performed using a Heart Team approach; thus, these credentialing criteria should be applied at the institutional level. Partnering societies used the ACC's policy on relationships with industry (RWI) and other entities to author this document (http://www.acc.org/guidelines/about-guidelines-and-clinical-documents). To avoid actual, potential, or perceived conflicts of interest due to industry relationships or personal interests, all members of the writing committee, as well as peer reviewers of the document, were asked to disclose all current healthcare-related relationships including those existing 12 months before the initiation of the writing effort. A committee of interventional cardiologists and surgeons was formed to include a majority of members with no relevant RWI and to be led by an interventional cardiology cochair and a surgical cochair with no relevant RWI. Authors with relevant RWI were not permitted to draft or vote on text or recommendations pertaining to their RWI. RWI were reviewed on all conference calls and updated as changes occurred. Author and peer reviewer RWI pertinent to this document are disclosed in the Appendices. In addition, to ensure complete transparency, authors' comprehensive disclosure information (including RWI not pertinent to this document) is available in Appendix AII. The work of the writing committee was supported exclusively by the Partnering societies without commercial support. SCAI, AATS, ACC, and STS believe that adherence to these recommendations will maximize the chances that these therapies will become a successful Part of the armamentarium for treating valvular heart disease in the United States. In addition, these recommendations will hopefully facilitate optimum quality during the delivery of this therapy, which will be important to the development and successful implementation of future, less invasive approaches to structural heart disease.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Catheterization and Cardiovascular Interventions, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) have Partnered to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns transcatheter pulmonic valve Replacement (tPVR). tPVR procedures are in their infancy with few reports available on which to base an expert consensus statement. Therefore, many of these recommendations are based on expert consensus and the few reports available. As the procedures evolve, technology advances, experience grows, and more data accumulate, there will certainly be a need to update this consensus statement. The writing committee and Participating societies believe that the recommendations in this report serve as appropriate requisites. In some ways, these recommendations apply to institutions more than to individuals. There is a strong consensus that these new valve therapies are best performed using a Heart Team approach; thus, these credentialing criteria should be applied at the institutional level. Partnering societies used the ACC's policy on relationships with industry (RWI) and other entities to author this document (http://www.acc.org/guidelines/about-guidelines-and-clinical-documents). To avoid actual, potential, or perceived conflicts of interest due to industry relationships or personal interests, all members of the writing committee, as well as peer reviewers of the document, were asked to disclose all current healthcare-related relationships including those existing 12 months before the initiation of the writing effort. A committee of interventional cardiologists and surgeons was formed to include a majority of members with no relevant RWI and to be led by an interventional cardiology cochair and a surgical cochair with no relevant RWI. Authors with relevant RWI were not permitted to draft or vote on text or recommendations pertaining to their RWI. RWI were reviewed on all conference calls and updated as changes occurred. Author and peer reviewer RWI pertinent to this document are disclosed in the Appendices. In addition, to ensure complete transparency, authors' comprehensive disclosure information (including RWI not pertinent to this document) is available in Appendix AII. The work of the writing committee was supported exclusively by the Partnering societies without commercial support. SCAI, AATS, ACC, and STS believe that adherence to these recommendations will maximize the chances that these therapies will become a successful Part of the armamentarium for treating valvular heart disease in the United States. In addition, these recommendations will hopefully facilitate optimum quality during the delivery of this therapy, which will be important to the development and successful implementation of future, less invasive approaches to structural heart disease.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    The Journal of Thoracic and Cardiovascular Surgery, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    Cardiac Catheterization Laboratory, North Shore Shore University Health System, 9669 North Ke 60076; Cardiothoracic Surgery, University of Colo Colorado 88045-2527; Cardiac Catheterization Hospital, Evanston, Illinois 60201; Cardiology Di pital, Walgreen Building 3rd Floor, Evanston, Illinoi Washington School of Medicine, Seattle, Washin Regional Heart Center, 1959 NE Pacific, Box 356171 98195; Rush Center for Congenital & Structural H Illinois 60612; Pediatric Cardiology, Rush Unive Chicago, Illinois 60612; Peter Munk Cardiac Cen Hospital, Toronto, Ontario M5G2C4; Saint Vincent Medical Center/Fallon Clinic, Worcester, Massach medical Associates, Northborough, Massachusetts; Center, Los Angeles, California 90048; DePartmen Health & Science University, 2761 SW Patton Ct., Po Lenox Hill Heart and Vascular Institute of New York 10021; Division of Cardiothoracic Surgery, delphia, Pennsylvania 19104; Cardiovascular C Hospital Baylor Plano, Plano, Texas 75093; The Da Broccoli Center for Aortic Diseases, The John

Ted Feldman - One of the best experts on this subject based on the ideXlab platform.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Journal of the American College of Cardiology, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, Additional Supporting Information may be found in the online version of this article. The

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Catheterization and Cardiovascular Interventions, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    PREAMBLE With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) have Partnered to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns transcatheter pulmonic valve Replacement (tPVR). tPVR procedures are in their infancy with few reports available on which to base an expert consensus statement. Therefore, many of these recommendations are based on expert consensus and the few reports available. As the procedures evolve, technology advances, experience grows, and more data accumulate, there will certainly be a need to update this consensus statement. The writing committee and Participating societies believe that the recommendations in this report serve as appropriate requisites. In some ways, these recommendations apply to institutions more than to individuals. There is a strong consensus that these new valve therapies are best performed using a Heart Team approach; thus, these credentialing criteria should be applied at the institutional level. Partnering societies used the ACC's policy on relationships with industry (RWI) and other entities to author this document (http://www.acc.org/guidelines/about-guidelines-and-clinical-documents). To avoid actual, potential, or perceived conflicts of interest due to industry relationships or personal interests, all members of the writing committee, as well as peer reviewers of the document, were asked to disclose all current healthcare-related relationships including those existing 12 months before the initiation of the writing effort. A committee of interventional cardiologists and surgeons was formed to include a majority of members with no relevant RWI and to be led by an interventional cardiology cochair and a surgical cochair with no relevant RWI. Authors with relevant RWI were not permitted to draft or vote on text or recommendations pertaining to their RWI. RWI were reviewed on all conference calls and updated as changes occurred. Author and peer reviewer RWI pertinent to this document are disclosed in the Appendices. In addition, to ensure complete transparency, authors' comprehensive disclosure information (including RWI not pertinent to this document) is available in Appendix AII. The work of the writing committee was supported exclusively by the Partnering societies without commercial support. SCAI, AATS, ACC, and STS believe that adherence to these recommendations will maximize the chances that these therapies will become a successful Part of the armamentarium for treating valvular heart disease in the United States. In addition, these recommendations will hopefully facilitate optimum quality during the delivery of this therapy, which will be important to the development and successful implementation of future, less invasive approaches to structural heart disease.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Catheterization and Cardiovascular Interventions, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) have Partnered to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns transcatheter pulmonic valve Replacement (tPVR). tPVR procedures are in their infancy with few reports available on which to base an expert consensus statement. Therefore, many of these recommendations are based on expert consensus and the few reports available. As the procedures evolve, technology advances, experience grows, and more data accumulate, there will certainly be a need to update this consensus statement. The writing committee and Participating societies believe that the recommendations in this report serve as appropriate requisites. In some ways, these recommendations apply to institutions more than to individuals. There is a strong consensus that these new valve therapies are best performed using a Heart Team approach; thus, these credentialing criteria should be applied at the institutional level. Partnering societies used the ACC's policy on relationships with industry (RWI) and other entities to author this document (http://www.acc.org/guidelines/about-guidelines-and-clinical-documents). To avoid actual, potential, or perceived conflicts of interest due to industry relationships or personal interests, all members of the writing committee, as well as peer reviewers of the document, were asked to disclose all current healthcare-related relationships including those existing 12 months before the initiation of the writing effort. A committee of interventional cardiologists and surgeons was formed to include a majority of members with no relevant RWI and to be led by an interventional cardiology cochair and a surgical cochair with no relevant RWI. Authors with relevant RWI were not permitted to draft or vote on text or recommendations pertaining to their RWI. RWI were reviewed on all conference calls and updated as changes occurred. Author and peer reviewer RWI pertinent to this document are disclosed in the Appendices. In addition, to ensure complete transparency, authors' comprehensive disclosure information (including RWI not pertinent to this document) is available in Appendix AII. The work of the writing committee was supported exclusively by the Partnering societies without commercial support. SCAI, AATS, ACC, and STS believe that adherence to these recommendations will maximize the chances that these therapies will become a successful Part of the armamentarium for treating valvular heart disease in the United States. In addition, these recommendations will hopefully facilitate optimum quality during the delivery of this therapy, which will be important to the development and successful implementation of future, less invasive approaches to structural heart disease.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    The Journal of Thoracic and Cardiovascular Surgery, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    Cardiac Catheterization Laboratory, North Shore Shore University Health System, 9669 North Ke 60076; Cardiothoracic Surgery, University of Colo Colorado 88045-2527; Cardiac Catheterization Hospital, Evanston, Illinois 60201; Cardiology Di pital, Walgreen Building 3rd Floor, Evanston, Illinoi Washington School of Medicine, Seattle, Washin Regional Heart Center, 1959 NE Pacific, Box 356171 98195; Rush Center for Congenital & Structural H Illinois 60612; Pediatric Cardiology, Rush Unive Chicago, Illinois 60612; Peter Munk Cardiac Cen Hospital, Toronto, Ontario M5G2C4; Saint Vincent Medical Center/Fallon Clinic, Worcester, Massach medical Associates, Northborough, Massachusetts; Center, Los Angeles, California 90048; DePartmen Health & Science University, 2761 SW Patton Ct., Po Lenox Hill Heart and Vascular Institute of New York 10021; Division of Cardiothoracic Surgery, delphia, Pennsylvania 19104; Cardiovascular C Hospital Baylor Plano, Plano, Texas 75093; The Da Broccoli Center for Aortic Diseases, The John

  • multisociety aats accf scai and sts expert consensus statement operator and institutional requirements for transcatheter valve repair and Replacement Part 1 transcatheter aortic valve Replacement
    Catheterization and Cardiovascular Interventions, 2012
    Co-Authors: Carl L Tommaso, Morton R Bolman, Ted Feldman, Joseph E Bavaria, Michael A Acker, Gabriel S Aldea, Duke E Cameron, Larry S Dean, Dave Fullerton, Ziyad M Hijazi
    Abstract:

    PREAMBLE The granting of staff privileges to physicians is an important mechanism to ensure quality care. The Joint Commission on Accreditation of Healthcare Organizations requires that medical staff privileges be based on professional criteria specified in medical staff bylaws. Physicians are charged with defining the criteria that constitute professional competence and with evaluating their peers accordingly. With the evolution of transcatheter aortic valve Replacement (TAVR), an important opportunity arises for both cardiologists and surgeons to come together to identify the criteria for performing these procedures. The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology Foundation (ACCF), and the Society of Thoracic Surgeons (STS) have, therefore, joined together to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns TAVR. As TAVR is in its infancy, there are few data on which to base this consensus statement. Therefore, many of these recommendations are based on expert consensus. As the procedures

Larry S Dean - One of the best experts on this subject based on the ideXlab platform.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Journal of the American College of Cardiology, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, Additional Supporting Information may be found in the online version of this article. The

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Catheterization and Cardiovascular Interventions, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    PREAMBLE With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) have Partnered to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns transcatheter pulmonic valve Replacement (tPVR). tPVR procedures are in their infancy with few reports available on which to base an expert consensus statement. Therefore, many of these recommendations are based on expert consensus and the few reports available. As the procedures evolve, technology advances, experience grows, and more data accumulate, there will certainly be a need to update this consensus statement. The writing committee and Participating societies believe that the recommendations in this report serve as appropriate requisites. In some ways, these recommendations apply to institutions more than to individuals. There is a strong consensus that these new valve therapies are best performed using a Heart Team approach; thus, these credentialing criteria should be applied at the institutional level. Partnering societies used the ACC's policy on relationships with industry (RWI) and other entities to author this document (http://www.acc.org/guidelines/about-guidelines-and-clinical-documents). To avoid actual, potential, or perceived conflicts of interest due to industry relationships or personal interests, all members of the writing committee, as well as peer reviewers of the document, were asked to disclose all current healthcare-related relationships including those existing 12 months before the initiation of the writing effort. A committee of interventional cardiologists and surgeons was formed to include a majority of members with no relevant RWI and to be led by an interventional cardiology cochair and a surgical cochair with no relevant RWI. Authors with relevant RWI were not permitted to draft or vote on text or recommendations pertaining to their RWI. RWI were reviewed on all conference calls and updated as changes occurred. Author and peer reviewer RWI pertinent to this document are disclosed in the Appendices. In addition, to ensure complete transparency, authors' comprehensive disclosure information (including RWI not pertinent to this document) is available in Appendix AII. The work of the writing committee was supported exclusively by the Partnering societies without commercial support. SCAI, AATS, ACC, and STS believe that adherence to these recommendations will maximize the chances that these therapies will become a successful Part of the armamentarium for treating valvular heart disease in the United States. In addition, these recommendations will hopefully facilitate optimum quality during the delivery of this therapy, which will be important to the development and successful implementation of future, less invasive approaches to structural heart disease.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    Catheterization and Cardiovascular Interventions, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    With the evolution of transcatheter valve Replacement, an important opportunity has arisen for cardiologists and surgeons to collaborate in identifying the criteria for performing these procedures. Therefore, The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) have Partnered to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns transcatheter pulmonic valve Replacement (tPVR). tPVR procedures are in their infancy with few reports available on which to base an expert consensus statement. Therefore, many of these recommendations are based on expert consensus and the few reports available. As the procedures evolve, technology advances, experience grows, and more data accumulate, there will certainly be a need to update this consensus statement. The writing committee and Participating societies believe that the recommendations in this report serve as appropriate requisites. In some ways, these recommendations apply to institutions more than to individuals. There is a strong consensus that these new valve therapies are best performed using a Heart Team approach; thus, these credentialing criteria should be applied at the institutional level. Partnering societies used the ACC's policy on relationships with industry (RWI) and other entities to author this document (http://www.acc.org/guidelines/about-guidelines-and-clinical-documents). To avoid actual, potential, or perceived conflicts of interest due to industry relationships or personal interests, all members of the writing committee, as well as peer reviewers of the document, were asked to disclose all current healthcare-related relationships including those existing 12 months before the initiation of the writing effort. A committee of interventional cardiologists and surgeons was formed to include a majority of members with no relevant RWI and to be led by an interventional cardiology cochair and a surgical cochair with no relevant RWI. Authors with relevant RWI were not permitted to draft or vote on text or recommendations pertaining to their RWI. RWI were reviewed on all conference calls and updated as changes occurred. Author and peer reviewer RWI pertinent to this document are disclosed in the Appendices. In addition, to ensure complete transparency, authors' comprehensive disclosure information (including RWI not pertinent to this document) is available in Appendix AII. The work of the writing committee was supported exclusively by the Partnering societies without commercial support. SCAI, AATS, ACC, and STS believe that adherence to these recommendations will maximize the chances that these therapies will become a successful Part of the armamentarium for treating valvular heart disease in the United States. In addition, these recommendations will hopefully facilitate optimum quality during the delivery of this therapy, which will be important to the development and successful implementation of future, less invasive approaches to structural heart disease.

  • scai aats acc sts operator and institutional requirements for transcatheter valve repair and Replacement Part ii mitral valve
    The Journal of Thoracic and Cardiovascular Surgery, 2014
    Co-Authors: Carl L Tommaso, Ted Feldman, Larry S Dean, Ziyad M Hijazi, David A Fullerton, Eric Horlick, Bonnie H Weiner, Evan M Zahn, Joaquin E Cigarroa, Carlos E Ruiz
    Abstract:

    Cardiac Catheterization Laboratory, North Shore Shore University Health System, 9669 North Ke 60076; Cardiothoracic Surgery, University of Colo Colorado 88045-2527; Cardiac Catheterization Hospital, Evanston, Illinois 60201; Cardiology Di pital, Walgreen Building 3rd Floor, Evanston, Illinoi Washington School of Medicine, Seattle, Washin Regional Heart Center, 1959 NE Pacific, Box 356171 98195; Rush Center for Congenital & Structural H Illinois 60612; Pediatric Cardiology, Rush Unive Chicago, Illinois 60612; Peter Munk Cardiac Cen Hospital, Toronto, Ontario M5G2C4; Saint Vincent Medical Center/Fallon Clinic, Worcester, Massach medical Associates, Northborough, Massachusetts; Center, Los Angeles, California 90048; DePartmen Health & Science University, 2761 SW Patton Ct., Po Lenox Hill Heart and Vascular Institute of New York 10021; Division of Cardiothoracic Surgery, delphia, Pennsylvania 19104; Cardiovascular C Hospital Baylor Plano, Plano, Texas 75093; The Da Broccoli Center for Aortic Diseases, The John

  • multisociety aats accf scai and sts expert consensus statement operator and institutional requirements for transcatheter valve repair and Replacement Part 1 transcatheter aortic valve Replacement
    Catheterization and Cardiovascular Interventions, 2012
    Co-Authors: Carl L Tommaso, Morton R Bolman, Ted Feldman, Joseph E Bavaria, Michael A Acker, Gabriel S Aldea, Duke E Cameron, Larry S Dean, Dave Fullerton, Ziyad M Hijazi
    Abstract:

    PREAMBLE The granting of staff privileges to physicians is an important mechanism to ensure quality care. The Joint Commission on Accreditation of Healthcare Organizations requires that medical staff privileges be based on professional criteria specified in medical staff bylaws. Physicians are charged with defining the criteria that constitute professional competence and with evaluating their peers accordingly. With the evolution of transcatheter aortic valve Replacement (TAVR), an important opportunity arises for both cardiologists and surgeons to come together to identify the criteria for performing these procedures. The Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology Foundation (ACCF), and the Society of Thoracic Surgeons (STS) have, therefore, joined together to provide recommendations for institutions to assess their potential for instituting and/or maintaining a transcatheter valve program. This article concerns TAVR. As TAVR is in its infancy, there are few data on which to base this consensus statement. Therefore, many of these recommendations are based on expert consensus. As the procedures